1 domain / 3 areas / 2 specializations
Tim Ferriss
Data updated
Tim Ferriss is a U.S.-based angel investor, author, and podcast host who has been angel investing in tech and consumer packaged goods startups since 2008. His own site describes him as an early-stage technology investor/advisor and notes that most of his portfolio investments have been seed or Series A, with some later-stage positions.
He matters in the psychedelic ecosystem because he has publicly backed psychedelic research and funding efforts, including major support for MDMA-assisted therapy and Johns Hopkins’ psychedelic research center. His public writing also says he shifted most of his focus away from startup investing and toward psychedelic science in 2015.
Investor Context
Angel InvestorsInvestment Context
This stakeholder is listed as an Angel Investor within Angel Investors. Its public geography context is global. Public stage signals include Seed and Series A/B. Public focus areas include Drug Development.
Public Portfolio Examples
- Johns Hopkins Center for Psychedelic and Consciousness Researchphilanthropic funding - part of $17 million in funding - Jan 1, 2019
- MAPS / MDMA-assisted therapy fundraisingphilanthropic challenge grant - $10 million challenge - Jun 12, 2020
Tim Ferriss appears to invest selectively and early, with a portfolio oriented toward companies he can actively help through fundraising, advising, PR/comms, and go-to-market support. Public materials show a broad early-stage investing history in technology and consumer products, while his psychedelic relevance is primarily through philanthropic and ecosystem support for psychedelic research rather than a clearly disclosed venture portfolio in the sector.
Investor Type
Angel Investor
Geographic Scope
Global
Psychedelic Focus
Psychedelic-Adjacent Focus
Engagement
Active
Investment Stage Focus
Investment Focus Areas
Recorded Investments
philanthropic funding - part of $17 million in funding
Publicly cited as one of the investors supporting the center’s funding.
The Emerging Revival of Psychedelics in NeuroscienceMAPS / MDMA-assisted therapy fundraising
Jun 12, 2020
philanthropic challenge grant - $10 million challenge
Directly tied to psychedelic medicine and MDMA-assisted therapy development.
Tim Ferriss Announces $10 Million, 90-Day Challenge to Fund Final Stages of Making MDMA a Medicine for PTSDFoundations & Philanthropy Snapshot
Grant-Making OrganizationsClassification
Individual Donor / Family Office Giving
Geography
Global
Coverage
Global
Last Verified
Apr 10, 2026
Funding Focus Areas
Support Types
Verification
Verified
Psychedelic Focus
Explicit Psychedelic Focus
Engagement Status
Active
Funded / Linked Stakeholders
Quick Facts
- Founded
- 2008
- HQ
- Austin, Texas, United States
- Website
- Visit